Tg Therapeutics Inc (TGTX)

07:43 AM

TG Therapeutics showcases BRIUMVI data at neurology meet - Investing.com

07:43 AM

07:30 AM

Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile - Stock Titan

07:30 AM

Apr 07, 2025

TG Therapeutics reports on MS treatment switch By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

TG Therapeutics reports on MS treatment switch - Investing.com India

Apr 07, 2025

Apr 07, 2025

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals - GlobeNewswire

Apr 07, 2025

Apr 07, 2025

Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short - Stock Titan

Apr 07, 2025

Apr 03, 2025

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and TG Therapeutics (TGTX) - The Globe and Mail

Apr 03, 2025

Apr 03, 2025

(TGTX) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Apr 03, 2025

Apr 02, 2025

TGTX Gains as Roche's Ocrevus Fails in Phase 3 Trial; Impacting MS Market Dynamics - GuruFocus

Apr 02, 2025

Apr 02, 2025

TG Therapeutics rises after trial setback for high dose version of Roche’s MS drug - MSN

Apr 02, 2025

Apr 02, 2025

TG Therapeutics stock rises as Roche’s trial fails (TGTX) - Seeking Alpha

Apr 02, 2025

Apr 02, 2025

CRUCIAL INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against TG Therapeutics, Inc. and Strongly Advises Investors with Losses to Contact the Firm - ACCESS Newswire

Apr 02, 2025

Mar 30, 2025

Should We Be Cautious About TG Therapeutics, Inc.'s (NASDAQ:TGTX) ROE Of 11%? - Yahoo Finance

Mar 30, 2025

Mar 25, 2025

Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength? - MSN

Mar 25, 2025

Mar 25, 2025

Why TG Therapeutics Stock Was Soaring This Week - MSN

Mar 25, 2025

Mar 25, 2025

Based On Its ROE, Is TG Therapeutics, Inc. (NASDAQ:TGTX) A High Quality Stock? - simplywall.st

Mar 25, 2025

Mar 23, 2025

(TGTX) Investment Analysis and Advice - Stock Traders Daily

Mar 23, 2025

Mar 21, 2025

TG Therapeutics stock soars to 52-week high of $43.03 By Investing.com - Investing.com South Africa

Mar 21, 2025

Mar 21, 2025

TG Therapeutics stock soars to 52-week high of $43.03 - Investing.com India

Mar 21, 2025

Mar 21, 2025

TG Therapeutics (TGTX) technical analysisTG Therapeutics (NASDAQ:TGTX) - Benzinga

Mar 21, 2025

Mar 19, 2025

TG Therapeutics (TGTX): Among the Best Short Squeeze Stocks to Buy According to Analysts - Yahoo Finance

Mar 19, 2025

Mar 17, 2025

Multiple Sclerosis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Medication, Epidemiology, Prevalence, Therapies and Companies by DelveInsight - The Globe and Mail

Mar 17, 2025

Mar 15, 2025

Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel (NASDAQ:DTIL) - Seeking Alpha

Mar 15, 2025

Mar 15, 2025

TG Therapeutics stock soars to 52-week high of $40.32 By Investing.com - Investing.com Australia

Mar 15, 2025

Mar 14, 2025

TG Therapeutics: Bright Outlook, Bolstered By Briumvi And Upcoming Trials (NASDAQ:TGTX) - Seeking Alpha

Mar 14, 2025

Mar 14, 2025

TG Therapeutics stock soars to 52-week high of $40.32 - Investing.com India

Mar 14, 2025

Mar 14, 2025

TG Therapeutics Stock (TGTX): Advancing MS Treatment - Value The Markets

Mar 14, 2025

Mar 14, 2025

Is TG Therapeutics, Inc. (TGTX) the Best Performing Growth Stock in 2025? - Insider Monkey

Mar 14, 2025

Mar 13, 2025

(TGTX) Technical Data - Stock Traders Daily

Mar 13, 2025

Mar 12, 2025

TG Therapeutics: Exciting Briumvi Performance, Looking To Re-Enter (NASDAQ:TGTX) - Seeking Alpha

Mar 12, 2025

Mar 12, 2025

10 Best Performing Growth Stocks in 2025 - Insider Monkey

Mar 12, 2025

Mar 12, 2025

Proficio Capital Partners LLC Buys Shares of 10,174 TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

Mar 12, 2025

Mar 11, 2025

TG Therapeutics call volume above normal and directionally bullish - TipRanks

Mar 11, 2025

Mar 11, 2025

Smartleaf Asset Management LLC Has $60,000 Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

Mar 11, 2025

Mar 09, 2025

TG Therapeutics (NasdaqCM:TGTX) Surges 28% Following US$23 Million Net Income Turnaround - Yahoo Finance

Mar 09, 2025

Mar 09, 2025

Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio? - Benzinga

Mar 09, 2025

Mar 09, 2025

Bank of New York Mellon Corp Increases Stake in TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

Mar 09, 2025

Mar 08, 2025

Q2 Earnings Forecast for TG Therapeutics Issued By B. Riley - Defense World

Mar 08, 2025

Mar 07, 2025

TGTX Surges on Strong Q4 Results and Briumvi Success - GuruFocus.com

Mar 07, 2025

Mar 07, 2025

Why TG Therapeutics Shares Are Soaring Now - TipRanks

Mar 07, 2025

Mar 07, 2025

Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week - MSN

Mar 07, 2025

Mar 07, 2025

TG Therapeutics Announces Schedule of Data Presentations - GlobeNewswire

Mar 07, 2025

Mar 07, 2025

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting - Yahoo Finance

Mar 07, 2025

Mar 07, 2025

Q1 Earnings Forecast for TG Therapeutics Issued By B. Riley - Defense World

Mar 07, 2025

Mar 06, 2025

This Biotech Stock Hits Buy Point After Earnings Burst - MSN

Mar 06, 2025

Mar 06, 2025

HC Wainwright Reaffirms “Buy” Rating for TG Therapeutics (NASDAQ:TGTX) - Defense World

Mar 06, 2025